Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Tension-Type Headache
Interventions
DRUG

TNX-201

TNX-201 capsule

DRUG

Placebo

Placebo capsule

Trial Locations (10)

23507

Duane G. Wombolt, MD, Norfolk

27103

PMG Research of Winston-Salem, LLC., Winston-Salem

27609

John Rubino, MD, Raleigh

30281

Nathan Segall, MD, CPI, Stockbridge

32720

Avail Clinical Research LLC., DeLand

37203

Stephan C. Sharp, MD, Nashville

44122

Rapid Medical Research, Inc., Cleveland

48104

Michigan Head-Pain Neurological Institute, Ann Arbor

55402

Gary D. Berman, MD, Minneapolis

95117

James D. Wolfe, MD, San Jose

All Listed Sponsors
lead

Tonix Pharmaceuticals, Inc.

INDUSTRY

NCT02423408 - Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache | Biotech Hunter | Biotech Hunter